Callan Capital, LLC Pfizer Inc Transaction History
Callan Capital, LLC
- $1.35 Billion
- Q1 2025
A detailed history of Callan Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Callan Capital, LLC holds 11,455 shares of PFE stock, worth $277,096. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,455
Previous 17,945
36.17%
Holding current value
$277,096
Previous $476,000
39.08%
% of portfolio
0.02%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding PFE
# of Institutions
3,371Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.18 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.04 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.5 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $136B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...